Celldex Therapeutics buy Wells Fargo & Company
Start price
20.08.25
/
50%
€18.40
Target price
20.08.26
€32.67
Performance (%)
49.51%
Price
08:14
?
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for Celldex Therapeutics has seen massive gains of 49.51%. This prediction currently runs until 20.08.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | 14.315% | 14.315% |
| iShares Core DAX® | 2,55 % | 0,56 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % |
| iShares S&P 500 | 1,93 % | -0,51 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (NASDAQ:CLDX) had its price target lowered by analysts at Wells Fargo & Company from $44.00 to $38.00. They now have an "overweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat